Pharmacogenetics and anaesthetic drugs: Implications for perioperative practice

被引:19
作者
Behrooz, Arash [1 ]
机构
[1] Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England
来源
ANNALS OF MEDICINE AND SURGERY | 2015年 / 4卷 / 04期
关键词
Anaesthetics; Pharmacogenetics; Perioperative medicine;
D O I
10.1016/j.amsu.2015.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pharmacogenetics seeks to elucidate the variations in individual's genetic sequences in order to better understand the differences seen in pharmacokinetics, drug metabolism, and efficacy between patients. This area of research is rapidly accelerating, aided by the use of novel and more economical molecular technologies. A substantial evidence base is being generated with the hopes that in the future it may be used to generate personalised treatment regimens in order to improve patient comfort and safety and reduce incidences of morbidity and mortality. Anaesthetics is an area of particular interest in this field, with previous research leading to better informed practice, specifically with regards to pseudocholinesterase deficiency and malignant hyperthermia. In this review, recent pharmacogenetic data pertaining to anaesthetic drugs will be presented and possible future applications and implications for practice will be discussed. (C) 2015 The Author. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.
引用
收藏
页码:470 / 474
页数:5
相关论文
共 47 条
  • [1] Ama Tori, 2010, AANA J, V78, P393
  • [2] The role of CACNA1S in predisposition to malignant hyperthermia
    Carpenter, Danielle
    Ringrose, Christopher
    Leo, Vincenzo
    Morris, Andrew
    Robinson, Rachel L.
    Halsall, P. Jane
    Hopkins, Philip M.
    Shaw, Marie-Anne
    [J]. BMC MEDICAL GENETICS, 2009, 10 : 104
  • [3] Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje
  • [4] Pharmacogenetics in perioperative medicine
    Cohen, Mindy
    Sadhasivam, Senthilkumar
    Vinks, Alexander A.
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2012, 25 (04) : 419 - 427
  • [5] A vision for the future of genomics research
    Collins, FS
    Green, ED
    Guttmacher, AE
    Guyer, MS
    [J]. NATURE, 2003, 422 (6934) : 835 - 847
  • [6] Daly A.K., 2012, PHARMACOGENETICS IND, P6
  • [7] Characterization of a Novel BCHE "Silent'' Allele: Point Mutation (p. Val204Asp) Causes Loss of Activity and Prolonged Apnea with Suxamethonium
    Delacour, Herve
    Lushchekina, Sofya
    Mabboux, Isabelle
    Bousquet, Aurore
    Ceppa, Franck
    Schopfer, Lawrence M.
    Lockridge, Oksana
    Masson, Patrick
    [J]. PLOS ONE, 2014, 9 (07):
  • [8] Dolzan V., 2012, PHARMACOGENETICS IND, P15
  • [9] Farhat K, 2013, EGYPT J MED HUM GEN, V14, P331
  • [10] Propofol infusion syndrome - An overview of a perplexing disease
    Fodale, Vincenzo
    La Monaca, Enza
    [J]. DRUG SAFETY, 2008, 31 (04) : 293 - 303